Principal Investigator On
Investigator On
Private Grant
awarded by JAZZ PHARMACEUTICALS, INC.
2018 - 2028
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2019 - 2025
Per Case Reimbursement COG NCORP Research Base
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2019 - 2025
Private Grant
awarded by BLUEBIRD BIO INC.
2020 - 2023
Identifying Predictors of Poor Health Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors
awarded by National Marrow Donor Program
2019 - 2023
PBMTC Study No. 1701 "Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children with B-ALL (Endrad) Trial"
awarded by CHILDREN'S HOSPITAL LA
2019 - 2022
Private Grant
awarded by NOVARTIS PHARMACEUTICALS CORPORATION
2018 - 2021
Project EveryChild APEC14B1
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2017 - 2021
AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2015 - 2021
Primary Immune Deficiency Treatment Consortium
awarded by University of California, San Francisco
2019 - 2021
Private Grant
awarded by ALEXION PHARMACEUTICALS, INC.
2021
Private Grant
awarded by BLUEBIRD BIO INC.
2019 - 2021
A Randomized Trial of Low Versus Moderate Exposure Busulfan for Infants with Severe Combined Immunodeficiency (SCID) Receiving TCRaß+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC “CSIDE” Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801
awarded by Childrens Hospital Los Angeles
2019 - 2020
Acute GVHD Suppression using Co-Stimulation Blockage to Expand Non-Malignant Transplant (ASCENT)
awarded by Emory University
2018 - 2020
A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2014 - 2020
St. Baldrick's Foundation Supplemental Reimbursement
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2018 - 2020
Primary Immune Deficiency Treatment Consortium
awarded by University of California, San Francisco
2016 - 2019
Per Case Reimbursement: COG NCORP Research Base
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2017 - 2019
Private Grant
awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW
2017 - 2019
Private Grant
awarded by JAZZ PHARMACEUTICALS, INC.
2017 - 2019
A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders/ PBMTC PIDTC #6901
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2014 - 2019
Predictive Biomarkers of Pediatric Graft-Versus-Host Disease
awarded by Canadian Institutes of Health Research
2014 - 2019
AAML 1031 - Bayer
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2017 - 2019
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2018 - 2019
Project Everychild APEC14B1
awarded by CHILDREN'S ONCOLOGY GROUP
2015 - 2018
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
awarded by New York Blood Center
2013 - 2018
St. Baldricks Fdn Supplemental Reimbursement
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2012 - 2018
11-TREO: A Phase II Study of Treosulfane/Fiudarabine/Low Dose Total Body Irradiation as a Preparative Regimen for Children with AMLIMDS Undergoing Allogeneic Hematopoietic Cell Transplantation
awarded by National Marrow Donor Program
2013 - 2017
CTSU: Phase II Supplemental Payments (N02-CM-62212)
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2012 - 2017
Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2015
BIQSFP-COG AALL1131 11XS189 Per Case Reimbursement
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2012 - 2015
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)
2014 - 2015
